Skip to main content
ChemoMetec logo

ChemoMetec — Investor Relations & Filings

Ticker · CHEMM ISIN · DK0060055861 LEI · 213800533NBKECGONO68 CO Manufacturing
Open in API
Filings indexed 538 across all filing types
Latest filing 2026-03-26 Director's Dealing
Country DK Denmark
Listing CO CHEMM

About ChemoMetec

https://chemometec.com

ChemoMetec is a global manufacturer specializing in high-precision automated cell counting and analysis instrumentation. The company develops and produces a range of advanced image cytometers and cell density analyzers, including the NucleoCounter® and XcytoMatic® series. These systems provide consistent, reproducible, and accurate cell count and viability data for a wide range of cell types. Key technologies include fluorescence microscopy, which enables trypan blue-free analysis, and specialized consumables designed to minimize human error. ChemoMetec's instruments are designed for regulated environments, offering software solutions compliant with FDA 21 CFR Part 11 and supporting Good Manufacturing Practice (GMP) workflows. The company serves customers in the biotechnology, pharmaceutical, and academic sectors, with applications in cell and gene therapy, cancer research, and bioprocessing.

Recent filings

Filing Released Lang Actions
Notification of managers’ transactions
Director's Dealing Classification · 1% confidence The document is an announcement titled “Notification of managers’ transactions” under Article 19 of EU Regulation No. 596/2014, detailing insider transactions by persons discharging managerial responsibilities and providing attachments of specific trade notifications. This corresponds to reports of personal share transactions by company directors/executives. Therefore, it matches the Director’s Dealing category.
2026-03-26 English
Adjustment of guidance for 2025/26
Earnings Release Classification · 1% confidence The document is a corporate press release (Meddelelse) announcing an adjustment to the company’s financial expectations (revenue and EBITDA guidance) for fiscal year 2025/26. It does not present full historical results or financial statements, nor is it an announcement of a report publication, governance change, or financing activity. This type of forward-looking update fits the profile of an Earnings Release (ER) guidance update rather than a detailed annual/interim report or a capital-markets transaction notice. FY 2025
2026-03-24 Danish
Adjustment of guidance for 2025/26
Management Reports Classification · 1% confidence The document is a standalone announcement by company management updating and explaining the business trends and revising full‐year guidance (revenue and EBITDA forecasts) for the 2025/26 financial year. This is not a full earnings release of results, not a regulatory filing merely announcing a report, nor a financing or capital‐structure update. Instead, it is management’s narrative on performance drivers and outlook – matching the Management Reports category (MDA).
2026-03-24 English
Notification of managers’ transactions
Director's Dealing Classification · 1% confidence The document is a standard regulatory form (Finanstilsynet) used to report transactions made by persons discharging managerial responsibilities (PDMRs). It explicitly lists the name of the director (Betina Hagerup), the issuer (ChemoMetec A/S), the nature of the transaction (purchase of shares), the price, and the volume. This falls under the category of Director's Dealing.
2026-03-02 Danish
Notification of managers’ transactions
Director's Dealing Classification · 1% confidence The document is titled 'Indberetning af ledende medarbejderes transaktioner' (Notification of transactions by persons discharging managerial responsibilities). It explicitly references Article 19 of EU Regulation 596/2014, which governs insider dealing and director's dealings. The document serves as a notification of a specific transaction by a board member (Betina Hagerup) and provides a link to the detailed report. This fits the definition of a Director's Dealing (DIRS) filing.
2026-03-02 Danish
Notification of managers’ transactions
Director's Dealing Classification · 1% confidence The document is a standard notification form for transactions by persons discharging managerial responsibilities (PDMRs), specifically detailing a share purchase by a member of the Board of Directors. This aligns perfectly with the definition of 'Director's Dealing' (DIRS), which covers personal share transactions by company directors and executives.
2026-03-02 Danish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.